# Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases

> **NCT06619808** · NA · RECRUITING · sponsor: **Jinling Hospital, China** · enrollment: 150 (estimated)

## Conditions studied

- Metabolic Dysfunction-associated Steatotic Liver Disease
- Hepatic Steatosis
- Non-alcoholic Fatty Liver Diseases

## Interventions

- **PROCEDURE:** Hyperbaric oxygen therapy

## Key facts

- **NCT ID:** NCT06619808
- **Lead sponsor:** Jinling Hospital, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-29
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-08-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06619808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06619808, "Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT06619808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*